Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The Trust is the cancer centre for North East London and provides a medical and haematological oncology service including bone marrow transplantation. The chemotherapy pharmacy department has a licensed chemotherapy production unit, providing over 45,000 doses of systemic anti-cancer treatments (SACT) per year.
Demand for the provision of SACT has been rising consistently year on year. As such the department has developed a strategy to meet this demand and ensure that patient treatment requirements can be met. This strategy includes maximising efficiency of our existing production capacity by outsourcing doses that can be manufactured externally, to quality standards and that will be safe for the patient.
The outsourced doses will be purchased in the form of both readymade dose banded products and patient specific doses.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| No Award was made | - | £6,000,000 | - |